Multiple sclerosis trials in Norway
6 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
- Where
- Drammen
- Age
- 18 years to 60 years
- People
- 990 worldwide
- Run by
- Zenas BioPharma (USA), LLC
See details and how to joinNCT07299019 · EU 2025-524322-18-00 - Phase 2Not yet taking people in NorwayTARGET-EBV in MS: Targeting Epstein Barr Virus with Tenofovir Alafenamide Fumarate in multiple sclerosis
- Where
- Bergen, Drammen, Lørenskog, Oslo, Stavanger
- Age
- 18 years and over
- People
- 61 worldwide
- Run by
- Oslo University Hospital HF
See details and how to join2025-522140-40-00 · EU 2025-522140-40-00 - Phase 3Taking peopleA clinical trial to find out how well LOU064 (remibrutinib) works and how safe it is for people with secondary progressive multiple sclerosis
- Where
- Aalesund, Bergen, Oslo
- Age
- 18 years and over
- People
- 677 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2025-521546-23-00 · EU 2025-521546-23-00 - No phaseTaking peopleMRI-Based Lesion Differentiation in Older Patients With Multiple Sclerosis
- Where
- Oslo
- Age
- 50 years to 80 years
- People
- 1,000
- Run by
- Oslo University Hospital
See details and how to joinNCT07444047 - No phaseTaking peopleRituximab and Ocrelizumab in Serum With Multiple Sclerosis
- Where
- Bergen
- Age
- 18 years to 60 years
- People
- 60
- Run by
- Haukeland University Hospital
See details and how to joinNCT06663111 - Phase 2Taking peopleNicotinamide Riboside Supplementation In Progressive Multiple Sclerosis
- Where
- Bergen
- Age
- 18 years to 65 years
- People
- 300
- Run by
- Haukeland University Hospital
See details and how to joinNCT05740722